Magnetoencephalography (MEG), Attention and Conscience
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01592175|
Recruitment Status : Unknown
Verified May 2012 by Institut National de la Santé Et de la Recherche Médicale, France.
Recruitment status was: Recruiting
First Posted : May 7, 2012
Last Update Posted : May 7, 2012
The tight relationship between attention and conscious perception makes them difficult to study in isolation and has led many scientists to closely link these two processes. However, while some authors argue that conscious perception cannot occurs without attention, magnetoencephalography (MEG) and fMRI studies had shown that attention and consciousness are two distinct brain processes.
If endogenously triggered attention and consciousness are dissociated, it has been proposed that orienting of exogenous attention is a necessary, though not sufficient, antecedent of conscious perception.
In the present study we used MEG to explore the neural correlates of exogenous attention and consciousness during visual processing.
|Condition or disease|
|Change in Sustained Attention Awareness Reaction Time|
|Study Type :||Observational|
|Estimated Enrollment :||8 participants|
|Official Title:||Spatio-temporal Dynamic of the Relationship Between Spatial Attention and Visual Awareness|
|Study Start Date :||March 2012|
|Estimated Primary Completion Date :||September 2014|
|Estimated Study Completion Date :||September 2014|
- Brain activity during visuo-spatial attention tasks [ Time Frame: Three years ]Magnetoencephalography will be used to measured cerebral evoked potential and oscillatory activity, while subjects will performed a visuo-spatial attention task.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01592175
|Contact: dimitri bayle, email@example.com|
|Paris, France, 75013|
|Contact: dimitri bayle, phd +33157274152 firstname.lastname@example.org|